Chelation trial in patients with cardiovascular disease

Affiliations

¹ Department of Nephrology and Clinical Poison Center, Chang Gung Memorial Hospital, Linkou Branch, and College of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address: m19570@adm.cgmh.org.tw.
² Department of Dermatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan.

Comment

Tzung-Hai Yen et al. Am Heart J. 2023 Feb.

. 2023 Feb:256:1.

doi: 10.1016/j.ahj.2022.10.084. Epub 2022 Nov 3.

¹ Department of Nephrology and Clinical Poison Center, Chang Gung Memorial Hospital, Linkou Branch, and College of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address: m19570@adm.cgmh.org.tw.
² Department of Dermatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan.

No abstract available

Comment in

Response to: Letter to the editor by Yen.
Lamas GA. Lamas GA. Am Heart J. 2023 Feb;256:158. doi: 10.1016/j.ahj.2022.10.085. Epub 2022 Nov 3. Am Heart J. 2023. PMID: 36336080 No abstract available.

The trial to assess chelation therapy 2 (TACT2): Rationale and design.
Lamas GA, Anstrom KJ, Navas-Acien A, Boineau R, Kim H, Rosenberg Y, Stylianou M, Jones TLZ, Joubert BR, Santella RM, Escolar E, Aude YW, Fonseca V, Elliott T, Lewis EF, Farkouh ME, Nathan DM, Mon AC, Gosnell L, Newman JD, Mark DB; TACT2 Investigators. Lamas GA, et al. Am Heart J. 2022 Oct;252:1-11. doi: 10.1016/j.ahj.2022.05.013. Epub 2022 May 19. Am Heart J. 2022. PMID: 35598636 Free PMC article. Clinical Trial.